Table 5.
Questionnaires | CSII | MDI | Control group | P value |
Total score | 21.5 ± 4.2 | 18.8 ± 6.6 | 24.8 ± 3.4 | 0.0004 |
ITEM - 1 | 3.2 ± 0.7 | 2.9 ± 1.0 | 4.1 ± 0.7 | < 0.0001 |
ITEM - 2 | 3.9 ± 0.7 | 3.2 ± 1.1 | 4.1 ± 0.9 | 0.0087 |
ITEM - 3 | 3.7 ± 1.4 | 2.6 ± 1.9 | 4.5 ± 0.8 | 0.0014 |
ITEM - 4 | 3.5 ± 1.4 | 3.5 ± 1.5 | 4.2 ± 0.9 | 0.1255 |
ITEM - 5 | 4.1 ± 0.7 | 3.1 ± 1.7 | 4.2 ± 0.7 | 0.1345 |
ITEM - 6 | 3.2 ± 1.0 | 3.6 ± 1.0 | 3.6 ± 1.0 | 0.2386 |
Questionnaires | Complications | No complications | Control group | P value |
Total score | 18.1 ± 5.9 | 22.1 ± 4.1 | 24.8 ± 3.4 | < 0.0001 |
ITEM - 1 | 2.9 ± 1.0 | 3.2 ± 0.6 | 4.1 ± 0.7 | < 0.0001 |
ITEM - 2 | 3.3 ± 1.1 | 3.8 ± 0.8 | 4.1 ± 0.9 | < 0.0133 |
ITEM - 3 | 2.5 ± 1.6 | 3.9 ± 1.4 | 4.5 ± 0.8 | < 0.0002 |
ITEM - 4 | 3.1 ± 1.5 | 3.6 ± 1.3 | 4.2 ± 0.9 | < 0.0257 |
ITEM - 5 | 3.1 ± 1.5 | 4.2 ± 0.8 | 4.2 ± 0.7 | < 0.0296 |
ITEM - 6 | 3.2 ± 0.9 | 3.4 ± 1.0 | 3.6 ± 1.0 | 0.2458 |
DM Diabetes Mellitus, MDI Multi Daily Infusion, CSII Continuous Subcutaneous Insulin Infusion, FSFI Female Sexual Function Index